Insulin use was reported for 34.6% of patients 180 days before the index date, and 62.1% had used either one or two medications in a GLD class other than GLP-1 RA, most often metformin (50.4%)
Hims & Hers default to the Wegovy pill as the first recommendation during treatment selection, but other options are available at the medication selection step
An unconventional mechanism of IL-1 secretion that requires type I IFN in lupus monocytes (Cold Spring Harbor Laboratory, 2023)
Results: Of 33 studies identified, five fulfilled the inclusion criteria with a total of 340 clinical subjects
May your vials stay potent, your storage stay cold, and your protocols stay consistent.
Learn more about trontinemab and other emerging Alzheimers therapeutics in late-stage clinical development